Noida: Jubilant Pharmova Limited has announced the appointment of Daniel J. O'Connor as the CEO of its Proprietary Novel ...
Graviton Bioscience Corporation, a clinical-stage biotechnology company developing selective ROCK2 inhibitors for metabolic, inflammatory, fibrotic, and central nervous system disorders, among other ...
The operational cleavage between the US public health and medical care systems contributed to the country’s difficulty in containing community spread of COVID-19 in the pandemic’s first months. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback